The management of retroperitoneal soft tissue sarcomas.
Over a 5-year period, all retroperitoneal soft tissue sarcomas (119) referred to the Royal Marsden Hospital, London, U.K., were recorded prospectively on a database and managed with a consistent treatment policy.
On multivariate analysis, the significant factors responsible for determining prognosis were grade and completeness of excision.
Despite improvements in surgical clearance rates (nearly 50% completely excised in this series), the prognosis was poor with 2and 5-year survival rates of 53 and 20%, respectively.
Further improvements in survival rates will depend on better adjuvant treatment.
Mots-clés Pascal : Sarcome, Partie molle, Rétropéritonéal, Homme, Pronostic, Traitement, Etude cohorte, Survie, Tumeur maligne, Rétropéritonéale pathologie, Epidémiologie
Mots-clés Pascal anglais : Sarcoma, Soft tissue, Retroperitoneal, Human, Prognosis, Treatment, Cohort study, Survival, Malignant tumor, Retroperitoneal disease, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0264405
Code Inist : 002B13D01. Création : 199608.